Market Overview

Neptune Acquires Biodroga for $15M in Cash, Stock

Share:

Neptune Technologies & Bioressources Inc. (NASDAQ: NEPT) announces that it has acquired Montreal based, privately held, Biodroga Inc. for $15 million in a combination of cash and stock.  All amounts in Canadian dollars.  
Biodroga is a leading solution provider of omega-3's and other functional ingredients to branded marketers in the nutraceutical industry, primarily in North America.  Their customized product offerings primarily include omega-3's, along with other essential nutritional ingredients that are used in specialty formulations.  Biodroga develops and distributes these solutions as turnkey finished supplements that are ready for sale, primarily as softgel capsules and liquids.     The business combination is highly complementary and further positions Neptune for success, by adding a new growth vehicle in a significantly larger addressable market.  "Biodroga offers a scalable solutions platform,

See full press release

Posted-In: M&A News Press Releases

 

Related Articles (NEPT)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

American Capital Concludes Initial Phase of Strategic Review; SaysWill Solicit Offers to Purchase Company or Business Lines

Benzinga's M&A Chatter for Thursday January 7, 2016: